ENANTA PHARMACEUTICALS INC - ENTA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 13, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 13, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 13, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 13, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 13, 2026 | — | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Feb 13, 2026 | Chief Scientific Officer | F | D | 3,413.0 | 14.25 | 48,635.25 | 374,854.0 | View | |
| Feb 13, 2026 | Chief Scientific Officer | A | A | 5,225.0 | 0.0 | 0.0 | 378,267.0 | View | |
| Feb 13, 2026 | Chief Scientific Officer | A | A | 1,650.0 | 0.0 | 0.0 | 373,042.0 | View | |
| Feb 13, 2026 | Chief Medical Officer | F | D | 3,413.0 | 14.25 | 48,635.25 | 25,254.0 | View | |
| Feb 13, 2026 | Chief Medical Officer | A | A | 5,225.0 | 0.0 | 0.0 | 28,667.0 | View | |
| Feb 13, 2026 | Chief Medical Officer | A | A | 1,650.0 | 0.0 | 0.0 | 23,442.0 | View | |
| Feb 13, 2026 | Chief Product Strategy Officer | F | D | 3,257.0 | 14.25 | 46,412.25 | 33,925.0 | View | |
| Feb 13, 2026 | Chief Product Strategy Officer | A | A | 4,987.0 | 0.0 | 0.0 | 37,182.0 | View | |
| Feb 13, 2026 | Chief Product Strategy Officer | A | A | 1,575.0 | 0.0 | 0.0 | 32,195.0 | View | |
| Feb 13, 2026 | Chief Business Officer | F | D | 3,257.0 | 14.25 | 46,412.25 | 41,634.0 | View | |
| Feb 13, 2026 | Chief Business Officer | A | A | 4,987.0 | 0.0 | 0.0 | 44,891.0 | View | |
| Feb 13, 2026 | Chief Business Officer | A | A | 1,575.0 | 0.0 | 0.0 | 39,904.0 | View | |
| Feb 13, 2026 | Chief Legal Officer | F | D | 1,902.0 | 14.25 | 27,103.5 | 3,591.0 | View | |
| Feb 13, 2026 | Chief Legal Officer | A | A | 4,175.0 | 0.0 | 0.0 | 5,493.0 | View | |
| Feb 13, 2026 | Chief Legal Officer | A | A | 1,318.0 | 0.0 | 0.0 | 1,318.0 | View | |
| Feb 13, 2026 | President and CEO | F | D | 6,155.0 | 14.25 | 87,708.75 | 871,871.0 | View | |
| Feb 13, 2026 | President and CEO | A | A | 15,200.0 | 0.0 | 0.0 | 878,026.0 | View | |
| Feb 13, 2026 | President and CEO | A | A | 4,800.0 | 0.0 | 0.0 | 862,826.0 | View | |
| Dec 05, 2025 | Chief Business Officer | S | D | 1,394.0 | 14.23 | 19,836.62 | 38,329.0 | View | |
| Dec 05, 2025 | Chief Product Strategy Officer | S | D | 2,106.0 | 14.23 | 29,968.38 | 30,620.0 | View | |
| Dec 05, 2025 | Chief Scientific Officer | S | D | 2,390.0 | 14.23 | 34,009.7 | 371,392.0 | View | |
| Dec 05, 2025 | President and CEO | S | D | 4,743.0 | 14.23 | 67,492.89 | 858,026.0 | View | |
| Dec 05, 2025 | See Remarks | S | D | 323.0 | 14.23 | 4,596.29 | 8,377.0 | View | |
| Dec 05, 2025 | Chief Medical Officer | S | D | 798.0 | 14.23 | 11,355.54 | 21,792.0 | View | |
| Dec 05, 2025 | See Remarks | S | D | 542.0 | 14.23 | 7,712.66 | 16,348.0 | View | |
| Dec 03, 2025 | President and CEO | F | D | 1,885.0 | 14.12 | 26,616.2 | 862,769.0 | View | |
| Dec 03, 2025 | Chief Scientific Officer | F | D | 753.0 | 14.12 | 10,632.36 | 373,782.0 | View | |
| Dec 03, 2025 | Chief Product Strategy Officer | F | D | 753.0 | 14.12 | 10,632.36 | 32,726.0 | View | |
| Dec 03, 2025 | Chief Business Officer | F | D | 498.0 | 14.12 | 7,031.76 | 39,723.0 | View | |
| Dec 03, 2025 | See Remarks | S | D | 207.0 | 13.96 | 2,889.72 | 8,700.0 | View | |
| Dec 03, 2025 | See Remarks | F | D | 85.0 | 14.12 | 1,200.2 | 8,907.0 | View | |
| Dec 03, 2025 | See Remarks | S | D | 380.0 | 13.96 | 5,304.8 | 16,890.0 | View | |
| Dec 03, 2025 | See Remarks | F | D | 105.0 | 14.12 | 1,482.6 | 17,270.0 | View | |
| Nov 26, 2025 | Chief Scientific Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Nov 26, 2025 | Chief Medical Officer | A | A | 110,000.0 | 0.0 | 0.0 | 110,000.0 | View | |
| Nov 26, 2025 | Chief Legal Officer | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Nov 26, 2025 | Chief Product Strategy Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Nov 26, 2025 | Chief Business Officer | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Nov 26, 2025 | See Remarks | A | A | 12,925.0 | 0.0 | 0.0 | 12,925.0 | View | |
| Nov 26, 2025 | See Remarks | A | A | 6,463.0 | 0.0 | 0.0 | 17,375.0 | View | |
| Nov 26, 2025 | See Remarks | A | A | 6,325.0 | 0.0 | 0.0 | 6,325.0 | View | |
| Nov 26, 2025 | See Remarks | A | A | 3,163.0 | 0.0 | 0.0 | 8,992.0 | View | |
| Nov 26, 2025 | President and CEO | A | A | 310,000.0 | 0.0 | 0.0 | 310,000.0 | View |